With technology-driven growth stocks propelling the S&P 500 to new heights, dividend stocks have often found themselves playing catch-up. Yet, even in this market environment, some dividend-paying com
Amgen shares have outperformed IBB by over 40% in the past year, driven higher by a major surge post-earnings in May. With a current price-to-earnings multiple in the mid-teens, I assert that solid an

The 3 Best Healthcare Stocks to Buy in July 2024

06:35am, Thursday, 04'th Jul 2024
The COVID-19 pandemic emphasized the importance of healthcare companies. Consistent breakthroughs, improved products and relatively consistent growth make these companies fan-favorite picks for invest

Forget Eli Lilly: 3 Biotech Stocks to Buy Instead

05:50am, Thursday, 04'th Jul 2024
Amgen is much cheaper than Eli Lilly. Vertex Pharmaceuticals has several major growth drivers.

Buy 2 July Dow Dogs And Watch 6

03:59pm, Wednesday, 03'rd Jul 2024
"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to numerous investors

Weighing the Future of Weight Loss Drugs

01:44pm, Tuesday, 02'nd Jul 2024
How are obesity drugs impacting other industries? Julia Angeles discusses the future of weight loss drugs.
Amgen has maintained an impressive dividend streak over the past decade. The company's business should allow it to maintain this momentum for a while.
24/7 Wall St. Insights Jefferies is one of Wall Street's fastest-growing firms.

Can Amgen Stock Keep Trouncing the S&P 500?

06:45am, Thursday, 27'th Jun 2024
Amgen has been one of the best performing stocks since its IPO in 1983. Over the prior 12 months, the biotech's shares have continued this rich tradition.
Novo Nordisk (NVO) and Eli Lilly (LLY) both made headlines recently with positive drug trial results for their respective GLP-1 weight-loss drugs, as well as their approval in China. While these names
Amgen (AMGN) closed at $319.31 in the latest trading session, marking a +0.36% move from the prior day.

Where Will Amgen Be in 5 Years?

08:15am, Thursday, 20'th Jun 2024
The drugmaker has a promising weight-loss drug in clinical trials, MariTide, which could be a game changer. Recent acquisitions have bolstered Amgen's portfolio, which could pave the way for even more
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Biotech stocks operate under a core ethos. While there's been much talk about financially viable sectors – from tech to cryptocurrencies to even precious metals – when you think about it, nothing

Amgen: You Haven't Seen Anything Yet

11:30am, Monday, 17'th Jun 2024
Amgen continues to delight investors with the growth in sales of its key blockbusters and the expansion of its portfolio of medications. In mid-June, Amgen pleased investors by announcing that the FDA
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE